• News Categories
    ▼
    • Surveillance & Technology
    • U.S. News & Reports
    • International News
    • Finance
    • Defense & Security
    • Politics
    • Videos
  • Blog
  • Directory
  • Support Us
  • About
  • Contact

T-Room

The Best in Alternative News

  • News Categories
    • Surveillance & Technology
    • U.S. News & Reports
    • International News
    • Finance
    • Defense & Security
    • Politics
    • Videos
  • Blog
  • Directory
  • Support Us
  • About
  • Contact

August 12, 2020 at 5:55 pm

Ten Experts on a NIH Wuhan Virus Panel Have Ties to Companies Involved in Wuhan Virus Treatment…

National_Institutes_of_Health
ParlerGabTruth Social

Members of the National Institutes of Health’s COVID-19 Treatment Guidelines Panel have financial ties to a company behind clinical trials of a drug to treat coronavirus, as well as to another large pharmaceutical company involved with developing a COVID-19 vaccine.

According to the NIH, members of the panel include U.S. physicians, statisticians, and other experts who are developing treatment guidelines on COVID-19 “intended for healthcare providers.”

A total of eight panel members list a financial relationship with Gilead Sciences on the panel’s Financial Disclosure for Companies Related to COVID-19 Treatment or Diagnostics document: Judith Aberg, MD, Adaora Adimora, MD, Jason Baker, MD, Roger Bedimo, MD, Eric Daar, MD, David V. Glidden, PhD, Susanna Naggie, MD, and Pablo Tebas, MD.

The U.S. has reportedly bought almost all of Gilead Sciences’ supply of the COVID-19 drug remdesivir. The company announced on June 1 the results of a phase 3 clinical trial of the drug in patients with moderate COVID-19.

On Monday, Gilead applied for FDA approval of remdesivir, which has been available for emergency use with patients hospitalized with severe cases of COVID-19.

“The data shows that remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery,” Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), announced back on April 29 in an interview with NBC News, citing results of a large international study sponsored by his NIAID.

“And all of the other trials that are taking place now have a new standard of care,” said Fauci…

ParlerGabTruth Social
Continue Reading
This website lives off the kindness of your donations. If you would like to support The T-Room please visit our PayPal.

Editor’s Picks

BRINGING THE HOSTAGES HOME: Trump and Rubio, With the Help of El Salvador’s Bukele, Secure the Release of All ‘Wrongfully Detained’ Americans in Venezuela…

A MUST WATCH: Tucker Carlson and Darryl Cooper on the True History of Jeffrey Epstein and Ongoing Cover-Up…

MANDELSON’S REVENGE: How Britain’s New Ambassador Plans to DESTROY Trump’s Economic Revolution…

The Director of National Intelligence Walks You Through the Creation of the Russia Hoax…

NEW EVIDENCE OF OBAMA ADMINISTRATION CONSPIRACY TO SUBVERT PRESIDENT TRUMP’S 2016 VICTORY AND PRESIDENCY…

Any publication posted at The T-Room and/or opinions expressed therein do not necessarily reflect the views of The T-Room. Such publications and all information within the publications (e.g. titles, dates, statistics, conclusions, sources, opinions, etc) are solely the responsibility of the author of the article, not The T-Room.

Twitter Icon

View Old Archives

Copyright © 2025 T-Room

Site by Creative Visual Design